← Study Library
Animal · 2022
Preclinicalcounts toward this tierImprovement of tissue-specific distribution and biotransformation potential of nicotinamide mononucleotide in combination with ginsenosides or resveratrol
Bai LB, Yau LF, Tong TT, Chan WH, Zhang W, Jiang ZH · Pharmacology Research & Perspectives
Preclinicalcounts toward this tier
The only direct test of the NMN-plus-resveratrol pairing found: in healthy mice the combination raised NAD+ 1.59-fold in heart and 1.72-fold in skeletal muscle compared with NMN alone (both p<0.001). Joint tissue was not among the six tissues measured.
- Population
- Healthy mice; NAD+ measured in brain, heart, kidney, liver, lung and muscle
- Intervention
- Oral NMN 500 mg/kg plus resveratrol 50 mg/kg (or ginsenosides Rh2&Rg3)
- Comparator
- Oral NMN alone
- Limitations
- Healthy-mouse pharmacokinetics with no disease model and no functional endpoint; nothing measured in cartilage or any joint; single dosing regimen. Full text read.
Cited by
1 entry references this study
- NMN / NAD+ precursorsPRECL.
Supplements → Vitamins & cofactors